|
J Biol Chem, Vol. 274, Issue 28, 19565-19572, July 9, 1999
Assembly and Secretion of Chylomicrons by Differentiated
Caco-2 Cells
NASCENT TRIGLYCERIDES AND PREFORMED PHOSPHOLIPIDS ARE
PREFERENTIALLY USED FOR LIPOPROTEIN ASSEMBLY*
Jayraz
Luchoomun and
M. Mahmood
Hussain§
From the Department of Biochemistry, School of Medicine, MCP
Hahnemann University, Philadelphia, Pennsylvania 19129
 |
ABSTRACT |
To develop a cell culture model for chyclomicron
(CM) assembly, the apical media of differentiated Caco-2 cells were
supplemented with oleic acid (OA) together with either albumin or
taurocholate (TC). The basolateral media were subjected to sequential
density gradient ultracentrifugations to obtain large CM, small CM, and very low density lipoproteins (VLDL), and the distribution of apoB in
these fractions was quantified. In the absence of OA, apoB was secreted
as VLDL/LDL size particles. Addition of OA ( 0.8 mM)
with TC, but not with albumin, resulted in the secretion of one-third
of apoB as CM. Lipid analysis revealed that half of the secreted
phospholipids (PL) and triglycerides (TG) were associated with CM. In
CM, TG were 7-11-fold higher than PL indicating that CM were TG-rich
particles. Secreted CM contained apoB100, apoB48, and other
apolipoproteins. Secretion of large CM was specifically inhibited by
Pluronic L81, a detergent known to inhibit CM secretion in animals.
These studies demonstrate that differentiated Caco-2 cells assemble and
secrete CM in a manner similar to enterocytes in vivo.
Next, experiments were performed to identify the sources of lipids used
for lipoprotein assembly. Cells were labeled with [3H]glycerol for 12 h, washed, and supplemented with
OA, TC, and [14C] glycerol for various times to induce
CM assembly and to radiolabel nascent lipids. TG and PL were extracted
from cells and media and the association of preformed and nascent
lipids with lipoproteins was determined. All the lipoproteins contained
higher amounts of preformed PL compared with nascent PL. VLDL contained
equal amounts of nascent and preformed TG, whereas CM contained higher amounts of nascent TG even when nascent TG constituted a small fraction
of the total cellular pool. These studies indicate that nascent TG and
preformed PL are preferentially used for CM assembly and provide a
molecular explanation for the in vivo observations that the
fatty acid composition of TG, but not PL, of secreted CM reflects the
composition of dietary fat. It is proposed that in the intestinal cells
the preformed PL from the endoplasmic reticulum bud off with apoB as
primordial particles and the assembly of larger lipoproteins is
dependent on the synthesis and delivery of nascent TG to these particles.
 |
INTRODUCTION |
Assembly and secretion of chylomicrons
(CM),1 the very large
triglyceride-rich lipoprotein particles synthesized only by intestinal epithelial cells after a fat meal, are essential for the transport of
dietary fat and fat-soluble vitamins. The molecular mechanisms involved
in the assembly of these lipoproteins have not been elucidated mainly
due to lack of cell culture models that secrete these particles. Caco-2, human colon carcinoma, cells have been used as a model to study
intestinal lipid metabolisms (for reviews, see Refs. 1-4). These cells
secrete apoB-containing particles which have flotation properties
similar to those of plasma LDL (reviewed in Ref. 1). However,
supplementation of Caco-2 cells with oleic acid (OA) has generally been
shown to result in the secretion of more VLDL-sized particles and fewer
LDL size particles but not chylomicrons (for review, see Ref. 1). The
reasons for the lack of CM secretion are not known. One reason could be
low levels of apoB48 synthesized by these cells. In contrast to
enterocytes which mainly synthesize apoB48, Caco-2 cells mainly
synthesize apoB100 (2, 5-9). In a previous study, we showed that the inability of these cells to assemble CM was not due to limited synthesis of apoB48, since overexpression of apoB48 did not result in
the secretion of chylomicrons (10). Furthermore, lipid absorption and
transport were not impaired in mice expressing only apoB100 (11, 12).
These studies indicated that lipid transport involving CM is a property
of intestinal cells and is not totally dependent on apoB48 expression
since apoB100 can substitute for this function. Thus, in the present
study, we examined the hypothesis that the mode and amount of lipids
delivered to intestinal cells may be limiting for the assembly and
secretion of CM by Caco-2 cells. The hypothesis was based on the
observation that intestinal cells synthesize VLDL or CM during fasting
or postprandial states, respectively (13, 14). Furthermore, synthesis
of these two lipoproteins is affected differently during infusion of
egg phosphatidylcholine, different amounts of oleic acid, and Pluronic
L81 (15-17). We provide evidence that differentiated Caco-2 cells
assemble and secrete apoB-containing CM particles under optimal
conditions and that preformed phospholipids and nascent triglyceride
are preferentially used for the assembly of these particles.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Antibodies used for the determination of apoB
have been described (18, 19). OA, taurocholate (TC), fatty acid free
bovine serum albumin (BSA), and other chemicals were obtained from
Sigma. Pluronic L81 was kindly provided by the BASF Corp. (Washington, NJ), and was freshly prepared in media for each experiment.
Cell Cultures--
Caco-2 cells were obtained from the American
Type Culture Collection (Rockville, MD), and grown in Dulbecco's
modified essential medium containing high glucose, 20% fetal bovine
serum (FBS), and a 1% antibiotic:antimycotic mixture. Half of the
cells from a 70-80% confluent 75-mm2 flask were divided
into 12 Transwells (24 mm diameter, 3 µM pore size,
Corning Costar Corp., Cambridge, MA) and the medium was changed every
other day for 21 days. This treatment is known to induce
differentiation of Caco-2 cells into enterocyte-like cells (1, 3, 20,
21). To prepare OA:TC (20 × 1.6:0.5 mM) stocks, required amounts of OA were added to 10 mM TC solution,
mixed by swirling, and incubated at 37 °C until a clear solution was obtained. To prepare OA:BSA (10 × 1.6:3.15 mM)
stocks, required amounts of OA were added to 31.5 mM BSA
solution, mixed by swirling, and incubated at 37 °C until a clear
solution was obtained. These stocks were filtered using a 0.2-µm
filter and stored at 20 °C. For experiments, cells were then
incubated with 2 ml of medium containing 20% FBS, OA with either BSA
or TC on the apical side of the Transwells for different times. The
basolateral side received 2 ml of either serum-free medium or
serum-free media containing 0.1% FBS. Basolateral conditioned media
were subjected to sequential density gradient ultracentrifugation.
Density Gradient Ultracentrifugation--
Conditions were
optimized to isolate large CM, small CM, and VLDL from cell culture
media by sequential ultracentrifugation based on methods used to
isolate these particles from lymph and plasma (22-24). In preliminary
studies, it was observed that adjustment of the density of the
conditioned media to 1.10 g/ml (24) followed by overlaying of
d < 1.006 g/ml density solution was crucial for the
reproducible separation of these lipoproteins from cell culture media.
Analytical ultracentrifugation was preferred to light scattering or
electron microscopy because rapidly floating units during
centrifugation are more homogeneous (reviewed in Ref. 25).
To the conditioned media (4 ml) was added KBr (0.57 g) to obtain a
density of 1.10 g/ml. The media was then overlaid with 3 ml each of
1.063 and 1.019 g/ml, and 2 ml of 1.006 g/ml density solutions using
the Auto Density Flow (Buchler Instruments, Lenexa, KS) and subjected
to sequential ultracentrifugation (24). To obtain large CM
(Sf > 400), samples were ultracentrifuged (SW41
rotor, 33 min, 40,000 rpm, 15 °C) and the top 1 ml was collected. The samples in the ultracentrifuge tubes were then overlaid with 1 ml
of d = 1.006 g/ml solution. Small CM
(Sf 60-400, 1 ml) were obtained from the top after
a second ultracentrifugation (3 h and 28 min, 40,000 rpm, 15 °C).
The top 1 ml was again replenished with d = 1.006 g/ml
solution and ultracentrifuged for 17 h. The first 1-ml fraction
collected from the top represented VLDL (d < 1.006 g/ml, Sf 20-60). The rest of the gradient was fractionated into additional seven 1.5-ml fractions. The fractions 2-4
and 5-7 were considered intermediate density lipoprotein/LDL (d = 1.02-1.063 g/ml) and high density
lipoprotein/bottom (1.063-1.1 g/ml), respectively.
Measurement of ApoB--
ApoB was quantified in the conditioned
media and in different density gradient fractions using a sandwich
enzyme-linked immunosorbent assay (18, 19) based on the binding of apoB
to immobilized monoclonal antibody, 1D1, that recognizes an epitope in
the N terminus (amino acids 474-539) of human apoB (26, 27). The recovery of apoB during ultracentrifugation ranged between 45 and 70%
in earlier experiments when basolateral surfaces were exposed to
serum-free media. In later experiments, addition of 0.1% FBS to
serum-free conditioned media increased the recovery to 60-90% without
affecting the distribution of apoB in different lipoprotein fractions.
In all figures and tables, apoB (% of total secreted) present in VLDL,
small CM, and large CM is shown. Differences in the amounts of apoB
under various conditions were analyzed by Student's t test
using Primer of Bio-statistics (McGraw-Hill Co., New York).
Radiolabeling of Cells and Protein Analysis--
Differentiated
Caco-2 cells were radiolabeled under different conditions by placing
[35S]Met/Cys radiolabeling mixture (150 µCi/ml, NEN
Life Science Products, Boston, MA) in Cys/Met-free medium containing
20% FBS at the apical side. The basolateral side received Cys/Met- and serum-free medium. After overnight incubations, basolateral conditioned media were subjected to density gradient ultracentrifugation as described above. Apolipoproteins were precipitated from different fractions (28). For this purpose, deoxycholate and trichloroacetic acid
were added to the fractions at final concentrations of 0.7 mM and 1 M, respectively (28). The mixtures
were incubated at 4 °C for 30 min, centrifuged, and proteins were
resuspended in sample buffers by incubating at 80 °C for 10 min.
Samples were applied to 3-15% polyacrylamide gradient gels,
electrophoresed, exposed to a PhosphorImager screen, and individual
bands were quantified.
Lipid Analyses--
Cells were labeled with either
[U-14C]glycerol (147.8 mCi/mmol) or
[1,2,3-3H]glycerol (200 mCi/mmol). Lipids were extracted
from cells or medium with isopropyl alcohol or chloroform:methanol
(2:1, v/v), respectively, and separated by thin layer chromatography on
LK5D silica gels (Whatman) using petroleum ether:ethyl ether:acetic acid (90:10:1, v/v). After visualization with iodine vapor, lipid bands
corresponding to triglycerides and phospholipids were scraped from the
plates, and counted after adding 3 ml of scintillation fluid.
 |
RESULTS |
Chylomicron Secretion by Differentiated Caco-2 Cells--
To
induce chylomicron secretion by Caco-2 cells, we added OA complexed
with either BSA or TC (Table I). BSA is
usually used for the delivery of fatty acids to cultured cells, whereas
TC is present in the intestinal lumen. Both of these vehicles have been
used to deliver fatty acids in different studies with Caco-2 cells (6,
7, 29-32). Lower concentrations of TC were used because higher
concentrations were reported to decrease apoB secretion in these cells
(33). First, we studied the effect of OA supplementation on total apoB
secretion. Supplementation of OA with BSA or TC increased apoB
secretion by 20% (Table I). The increase in apoB secretion was less
pronounced than that observed in other studies (6, 29, 30, 34) where
Caco-2 cells were supplemented with OA in serum-free media. Thus, OA
supplemented with serum-containing media has a modest effect on total
apoB secretion.
View this table:
[in this window]
[in a new window]
|
Table I
Induction of chylomicron secretion in differentiated Caco-2 cells
Differentiated Caco-2 cells cultured in media containing 20% FBS were
supplemented with either BSA or TC in the presence or absence of OA on
the apical side for 12 h. The basolateral media from two
Transwells were pooled and subjected to ultracentrifugation to obtain
various lipoprotein fractions as described under "Experimental
Procedures." ApoB present in the media and different fractions was
measured in triplicate. Distribution of apoB in larger lipoproteins is
shown. The data is representative of four independent experiments.
|
|
Next, we determined the distribution of apoB in different lipoprotein
fractions. When cells were incubated with either BSA or TC in the
absence of OA, no apoB was present in the large and small CM density
fractions. However, 5-11% of apoB was in the VLDL fraction.
Supplementation of OA as the BSA complex increased the amount of apoB
secreted as VLDL to 18%. Furthermore, 17% of apoB was now associated
with small CM. However, no apoB was in the large CM fraction.
Supplementation of OA with TC resulted in a significant increase of
apoB (23-24%) in VLDL and small CM. What is more important, 10% of
apoB was now associated with large CM, and approximately 35% of the
total secreted apoB was found associated with small and large CM. These
studies indicated that OA and TC had modest effects on the amount of
apoB secreted but had a profound effect on the secretion of apoB as
CM.
Next, we asked whether simultaneous incremental increases in OA and TC
would increase the secretion of larger lipoproteins (Table
II). Compared with TC-treated cells,
inclusion of OA:TC up to 1.6:1.0 mM resulted in a
~30-40% increase in apoB secretion. At OA:TC concentrations of
6.4:4.0 mM, total apoB secreted was significantly ( 60%)
decreased most likely due to OA toxicity since 4.0 mM TC in
the presence of 1.6 mM OA had no significant effect on apoB
secretion (Fig. 1B). Again,
secretion of apoB as part of CM was dependent on the presence of OA
(Table II). Maximum amounts of apoB in CM fractions were observed at
OA:TC concentrations of 1.6:1.0 mM. Higher concentrations
of OA:TC reduced the distribution of apoB into larger lipoproteins. In
addition, we studied the chronic effect of OA supplementation on the
secretion of apoB as CM. For this purpose, cells were exposed to OA:TC
(1.6:0.5 mM) for 8 h. Next, they were fed with fresh
media containing additional OA:TC and incubated for an additional
18 h. The percent of apoB secreted as CM was not affected by these
treatments (data not shown, see also Fig.
2 below) which indicated that up to
one-third of the total secreted apoB could be secreted as small and
large CM.
View this table:
[in this window]
[in a new window]
|
Table II
Effect of different concentrations of TC and OA on the secretion of
larger lipoproteins by differentiated Caco-2 cells
Differentiated Caco-2 cells were supplemented with different
concentrations of TC and OA on the apical side for 12 h as
described under "Experimental Procedures," and Table I. The
basolateral media from two Transwells were pooled and subjected to
ultracentrifugation as described under "Experimental Procedures."
The amounts of apoB present in larger lipoproteins are shown.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of different concentrations of oleic
acid and taurocholate on the secretion of large and small chylomicrons,
and VLDL by differentiated Caco-2 cells. Differentiated Caco-2
cells (21-day-old cultures in Transwells) were incubated (14 h) in
media containing 20% FBS with either TC (0.5 mM) and
several concentrations of OA (Panel A) or OA (1.6 mM) and various concentrations of taurocholate (Panel
B). The basolateral medium was subjected to density gradient
ultracentrifugation as described under "Experimental Procedures"
and the amounts of apoB in the different lipoprotein fractions were
determined by enzyme-linked immunosorbent assay (18, 19). In
panels A and B, average values of duplicate
determinations and mean ± S.D, of triplicate determinations,
respectively, are plotted. The data are representative of two
independent experiments.
|
|

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Apolipoproteins associated with larger
lipoproteins secreted by differentiated Caco-2 cells.
A, cells were incubated overnight with TC (0.5 mM); B, cells were incubated overnight with
OA:TC (1.6:0.5 mM); C, cells were preincubated
for 8 h with OA:TC (1.6:0.5 mM) and incubated
overnight with OA:TC (1.6:0.5 mM). Differentiated Caco-2
cells were radiolabeled by providing [35S]Met/Cys
labeling mixture (150 µCi/ml) to the apical side during overnight
incubation. Basolateral media were subjected to differential
ultracentrifugation to obtain different lipoproteins as described under
"Experimental Procedures." Proteins in different fractions were
precipitated using trichloroacetic acid/deoxycholate (28), dissolved in
a sample buffer, electrophoretically separated on 3-15%
polyacrylamide gradient gels, dried, and exposed to PhosphorImager
screens.
|
|
We then determined the optimum amounts of OA required for the assembly
and secretion of CM (Fig. 1A). Different concentrations of
OA had differential effects on the secretion of apoB in VLDL, small CM,
and large CM. Similar to results shown in Tables I and II, no apoB was
observed in the large or small CM fractions in the conditioned media
obtained from cells cultured in the absence of OA. However, 7% of apoB
was associated with the VLDL fraction (Fig. 1A). Addition of
0.4 mM OA resulted in a significant increase ( 15% each)
in the secretion of apoB as VLDL and small CM. Again, no apoB was found
associated with large CM. Increasing the concentration of OA to 0.8 mM resulted in further increases in the secretion of apoB
in the small CM and VLDL fractions ( 20% each). Now, however, 6%
of total apoB was recovered as large CM which reached a maximum of
8% at 1.6 mM OA. The effect of different concentrations
of OA was similar to that observed in vivo (35). In rats,
secretion of VLDL was saturated at OA infusion rates of 60 µmol/h
whereas infusion of higher amounts of OA ( 60 µmol/h) increased CM
secretion (35). These studies indicate that 0.8 mM OA was
required for the secretion of large CM by differentiated Caco-2 cells.
The importance of TC in the secretion of CM was then studied by
incubating Caco-2 cells with a constant amount of OA (1.6 mM) and different concentrations of TC (Fig.
1B). Total apoB secreted was not affected by increasing
concentrations of TC (data not shown). Similarly, higher concentrations
of TC had no additional effect on the secretion of apoB in large
CM, small CM, or VLDL fractions (Fig. 1B). Thus, the
secretion of larger lipoproteins was not enhanced by higher TC concentrations.
The studies described above indicated that OA induces secretion of CM
in differentiated Caco-2 cells. Next, we asked whether other fatty
acids would further enhance the secretion of CM. For this purpose,
cells were incubated with OA:TC and different fatty acids as described
in Table III. Different fatty acids did
not significantly increase total apoB secretion. Furthermore, palmitic and linoleic acids had no additional stimulatory effect on the secretion of lipoproteins by these cells.
View this table:
[in this window]
[in a new window]
|
Table III
Effect of different fatty acids on the secretion of lipoproteins in
differentiated Caco-2 cells
Culture media of differentiated Caco-2 cells were supplemented with
different fatty acids in the presence of 0.5 mM TC on the
apical side for 14 h. In addition, the apical media received
different fatty acids as indicated below. The basolateral media from
two Transwells were pooled and subjected to ultracentrifugation as
described under "Experimental Procedures."
|
|
Composition of Secreted Chylomicrons--
To determine the TG and
PL contents of the secreted lipoproteins, cells were labeled with
[3H]glycerol (36-38) and the distribution of these
lipids in different lipoprotein fractions was determined (Table
IV). Cells incubated with OA:TC secreted
58% and 13-fold higher amounts of PL and TG, respectively, compared
with cells incubated with OA:BSA indicating that significantly higher
amounts of TG were secreted by these cells. Most of the secreted TG
were in CM. Analysis of the media revealed that cells incubated with
OA:TC and OA:BSA secreted 48 and 24% of TG, and 46 and 11% of PL,
respectively, as large and small CM. The amounts of core lipids were
7-12-fold higher than surface lipids indicating that these particles
were TG-rich. The TG:PL ratios of 7 to 12 were the same as that
observed for CM isolated from lymph during the postprandial state (25,
39-44). A relationship has been described between TG:PL ratios and the volume:surface areas of the particles (40, 42) which has been used to
calculate particle diameters (41). Using the same equations, we
calculated that the diameters of CM secreted by Caco-2 cells ranged
between 104 and 162 nm. These values are in the range of diameters
reported for lymph and plasma CM (25, 41, 42, 44-46). Thus, Caco-2
cells secrete TG-rich particles with a lipid composition and a size
similar to that of lymph and plasma CM.
View this table:
[in this window]
[in a new window]
|
Table IV
Density distribution of newly synthesized triglycerides and
phospholipids in different fractions
Cells (two wells/treatment) were incubated overnight with either OA:TC
(1.6:0.5 mM) or OA:BSA (1.6:3.15 mM) and 10 µCi/ml [3H]glycerol. Basolateral media from two wells were
combined and used for lipid extraction and ultracentrifugation. After
ultracentrifugation, lipids were extracted from each lipoprotein
fraction, separated on thin layer chromatographic plates, and TG and PL
bands were scraped and counted. Lipids (pmol) present in larger
lipoproteins are shown. Values represent % of total secreted. Rest of
the lipids were in d > 1.006 g/ml fractions.
|
|
To determine the apolipoprotein composition of the secreted
lipoproteins, cells were incubated with either TC (Fig. 2, lane A), or OA:TC (lane B) for 18 h. In addition, cells
were incubated with OA:TC for 8 h followed by an additional
18 h with OA:TC (lane C). All cells received
[35S]Met/Cys labeling mixture during 18-h incubations.
Incubation with OA resulted in moderate increases (up to 40%) in the
secretion of apolipoproteins (Fig. 2, total). In the absence
of OA no apolipoproteins were observed in CM. However, OA treatment had
a profound effect on the distribution of apolipoproteins in these
lipoproteins. For example, apoBs in CM fractions increased by
15-100-fold (Fig. 2). Similar changes were also observed for other
apolipoproteins. Thus, secreted CM contained both apoB100 and apoB48
and other exchangeable apolipoproteins such as apoA-IV, apoE, apoA-I,
and apoCs.
Inhibition of Chylomicron Secretion--
After establishing
conditions for the induction of CM by differentiated Caco-2 cells, we
studied the inhibition of chylomicron secretion by Pluronic L81.
Pluronic L81 is a nonionic detergent that has been shown to inhibit CM
secretion in animal studies (16, 47, 48). Inclusion of Pluronic L81 up
to 8 µg/ml had no effect on the secretion of total apoB (Fig.
3A) indicating that it was not
toxic to cells. Next, we studied the effect of Pluronic L81 on the
distribution of apoB in different lipoprotein fractions (Fig.
3B). Pluronic L81 (1 µg/ml) significantly inhibited secretion of apoB as large CM particles but had no effect on its secretion as small CM and VLDL particles. At 2-4 µg/ml, Pluronic L81
had some inhibitory effect on the secretion of small CM. At higher
concentrations ( 4 µg/ml), Pluronic L81 inhibited the secretion of
both small CM and VLDL by 50% and 25%, respectively.
Consideration was given to the possibility that Pluronic L81 might
preferentially solubilize larger lipoproteins and affect the flotation
of apoB as large CM. For this purpose, conditioned media from cells
incubated with OA:TC was supplemented with different concentrations of
Pluronic L81 (0-8 µg/ml) prior to ultracentrifugation. Different
concentrations of Pluronic L81 had no effect on the distribution of
apoB in lipoprotein fractions (data not shown). These studies
indicated that at lower concentrations, Pluronic L81 specifically
inhibits the secretion of large CM.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Inhibition of chylomicron secretion by
Pluronic L81. Panel A, effect of Pluronic L81 on total
apoB secretion. Cells were incubated in media containing 20% FBS and
OA:TC (1.6:0.5 mM) in the presence of different indicated
amounts of Pluronic L81 for 18 h. Basolateral condition media was
used in triplicate to measure amounts of apoB secreted. Panel
B, effect of Pluronic L81 on the secretion of different
lipoproteins. Cells were incubated with different amounts of Pluronic
L81 as described in Panel A. Basolateral conditioned media
was subjected to density gradient ultracentrifugation and apoB was
measured in individual fractions as described under "Experimental
Procedures." The inhibition of apoB secretion in different
lipoprotein fractions at different concentrations of Pluronic L81 is
plotted.
|
|
Nascent Triglycerides and Preformed Phospholipids Are
Preferentially Used for CM Assembly and Secretion--
Studies were
then undertaken to identify the sources of lipids used for lipoprotein
assembly by differentiated Caco-2 cells. First, studies were limited to
studying the metabolism of the glycerol backbone and not the metabolism
of fatty acids. Several investigators have studied metabolism of fatty
acids and the effect of OA supplementation on cellular and secreted
lipids (6, 8, 21, 29, 30, 34, 49). Second, to simulate postprandial conditions, cells cultured under normal conditions were challenged with
OA. Third, glycerol radiolabeled with two different isotopes of similar
specific activities was used for labeling and data were converted to
nanomoles to compare different pools on molar basis. Fourth, cells were
prelabeled for 12 h to obtain uniform labeling of the cellular
pool. The experimental protocol consisted of labeling cells with
[3H]glycerol for 12 h in normal media followed by an
addition of fresh media containing OA:TC and
[14C]glycerol for different time periods (Fig.
4). Lipids containing [3H]-
and [14C]glycerol are referred to as "preformed" and
"nascent" pools, respectively. The top panels in Fig.
4A represent cellular changes in TG and PL pools. Before the
addition of the second label, the preformed TG were about 0.25 nmol/well (Fig. 4A, top left panel). This level of preformed
TG remained constant for about 4 h after the OA challenge.
Subsequently, there was an increase in the TG pool containing
[3H]glycerol which reached equilibrium around 9 h.
The increase in the [3H]glycerol-labeled TG could be
accounted for by a decrease in preformed PL between 4 and 6 h
(Fig. 4A, top right panel). It has been demonstrated that
the fatty acids of cellular PL pools contribute to TG synthesis (37).
The present studies indicated that the preformed TG pool was not
significantly affected by an OA challenge until 4 h. After this
time, there was an increase in TG containing [3H]glycerol
which was probably derived from the preformed PL pool by the action of
phospholipase C generating diacylglycerol intermediate. In contrast to
the preformed pool, the incorporation of [14C]glycerol
into nascent TG increased with time (the major increases occurred
between 4 and 9 h) and reached saturation around 9 h. At this
new steady state, the cellular levels of preformed and nascent TG were
similar. It should be emphasized that after the OA challenge there was
a significant increase ( 3-4-fold) in the total (preformed and
nascent) cellular TG levels. Thus, addition of OA results in increased
intracellular accumulation of TG.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Sources of lipids used for lipoprotein
assembly by differentiated Caco-2 cells. Cells were first labeled
for 12 h with [3H]glycerol (15 µCi/ml) to
obtain a uniform labeling of intracellular pools. Cells were then
washed and incubated with OA/TC and [14C]glycerol (1.5 µCi/ml) for various indicated times. Lipids containing
[14C]glycerol thus represented nascent pools. Basolateral
media were collected from individual wells at the indicated times and
subjected to ultracentrifugation as described under "Experimental
Procedures." Lipids were extracted from the different fractions,
counted in a scintillation counter, and converted to nanomole by
dividing the disintegrations/min by specific activity. A, top
panels represent amounts of preformed and nascent cellular TG and
PL levels at different time points, whereas the middle
panels represent the amounts of these lipids secreted into the
media. The bottom panels show ratios (preformed:nascent) for
TG and PL present in cells and media at different time points. B,
top, middle, and bottom panels show the distribution of
preformed and nascent TG and PL in large CM, small CM, and VLDL,
respectively.
|
|
In contrast to TG, the amounts of the preformed PL in cells were
1.25 nmol/well, a value that was almost 5-fold greater than cellular
TG levels before the addition of the new label and OA:TC indicating
that cellular PL pools were that much higher. It should be pointed out
the ratio of five between PL and TG was the same as that observed in
other studies where changes in cellular mass were measured (50). After
the addition of the OA:TC, there was a slight increase in preformed PL
which may be due to the utilization of precursors, such as glycerol
3-phosphate, for PL synthesis. After 4 h, there was some decrease
in [3H]glycerol-containing PL most likely due to its
conversion to TG since this decrease coincided with an increase in TG
containing [3H]glycerol. After the addition of OA, newly
available [14C]glycerol was predominantly used in the
first 4 h for PL synthesis compared with TG synthesis. However,
the incorporation of glycerol into PL quickly reached saturation around
4 h and was followed by a significant increase in TG synthesis.
These studies indicate that supplementation of OA first results in
significant increases in PL synthesis followed by a substantial
increase in TG synthesis.
The middle panels in Fig. 4 show the time course of TG and
PL secretion into the media. At early time points, the media
predominantly contained nascent TG even though the amounts of
intracellular nascent TG levels were significantly lower than the
preformed pool. For example, at 4 h there were 3-fold higher
amounts of preformed TG in cells and yet the secreted TG contained
2-fold higher amounts of nascent TG. Plotting the cellular
preformed:nascent TG ratios revealed that at 2 h there were 5-fold
greater amounts of preformed TG than the nascent TG levels (Fig.
4A, bottom left panel). This ratio decreased until 6 h
mainly due to an increase in nascent TG. After 6 h, the ratio did
not change reflecting equilibration of the two pools. In contrast, the
secreted lipoproteins contained twice the amounts of nascent TG
compared with preformed TG; the preformed:nascent TG ratio in the media
remained constant ( 0.5) at all times. These studies indicated that a
constant proportion of both of these pools were being secreted and that
the amounts of nascent TG secreted were twice that of preformed TG.
Examination of PL in the medium revealed that secreted PL were
predominantly derived from the preformed pool of PL. At any given time,
2-3-fold higher amounts of preformed PL were secreted compared with
newly synthesized PL. The changes in the ratios of these two pools
revealed that preformed PL levels in cells were always in excess
compared with nascent PL. In cells, this ratio decreased from 4 to 2 during the first 6 h, and remained constant at 2 after 6 h
indicating that there were 2-fold greater amounts of preformed PL than
nascent PL. In contrast, the amount of preformed PL secreted was
stabilized around 6 h at a ratio of 3 indicating that the secreted
PL contained 3-fold greater amounts of preformed PL than nascent PL.
Thus, the preformed PL pool appears to be preferred to the nascent PL
pool for secretion. These studies indicate that in contrast to cellular
TG levels, cellular PL levels change modestly (increase of about 30%).
Furthermore, the nascent TG and preformed PL are preferentially
secreted into the medium by these cells.
Fig. 4B shows the distribution of different lipid pools in
secreted lipoproteins. The amounts of nascent TG secreted as large and
small CM were significantly higher (2-3-fold) than preformed TG (Fig.
4B). VLDL also contained higher amounts of nascent TG; however, the differences between nascent and preformed TG pools were
not as significant as in the CM. In contrast to TG, all lipoproteins contained significantly higher amounts of the preformed PL compared with nascent PL. The increased amounts of preformed PL secreted compared with nascent PL were not simply due to higher intracellular levels, because the preformed:nascent ratio in lipoproteins was higher
than that present in cells. These data indicated that preformed PL and
nascent TG are preferentially used for lipoprotein biosynthesis.
 |
DISCUSSION |
Assembly and Secretion of CM--
We have provided evidence for
the synthesis and secretion of apoB-containing CM by differentiated
Caco-2 cells based on four different criteria that are characteristic
of CM assembly by enterocytes. First, synthesis was induced after
providing high concentrations of OA which probably mimicked the
postprandial state. Second, secreted CM were shown to have flotation
properties similar to those isolated from either lymph or plasma.
Third, it was demonstrated that CM were TG-rich particles based on the
amounts of TG associated with these particles and the ratio between
surface and core lipids (Table IV). Fourth, we studied the effect of a
physiologic inhibitor of CM secretion, Pluronic L81, to document that
CM secretion was similarly inhibited (Fig. 2B) in cell
cultures as in animal studies (16, 47, 48).
Several studies have documented that supplementation of OA to Caco-2
cells results in the redistribution of normally secreted LDL size
particles into VLDL size particles (1, 6, 7, 30). We have shown that
secretion of lipoproteins can be further modulated by OA
supplementation to obtain secretion of small and large CM. In some
studies, OA was delivered to Caco-2 cells as part of TC micelles (21,
32, 50, 51). In these studies the concentrations of OA used were below
0.8 mM; a concentration that we found to be less than
the optimum amount required for CM secretion (Fig. 1A).
Thus, Caco-2 cells assemble and secrete significant amounts of CM when
OA is provided under optimal conditions.
High concentrations of OA complexed to albumin have been provided to
these cells in earlier studies (5-8, 29, 30, 34). Consistent with
these studies, Caco-2 cells provided with OA·BSA complexes secreted
VLDL but not large CM (Table I). On the other hand, OA:TC supported CM
secretion. Several studies have documented that OA is taken up more
efficiently by Caco-2 cells when provided with TC compared with BSA
(20, 32, 49). Thus, rapid and efficient delivery of OA may be important
for the assembly and secretion of large CM. Rapid and efficient
delivery of OA may occur by saturable protein-mediated and
non-saturable diffusion processes (for reviews, see Refs. 52 and
53).
Characteristic Features of Chylomicrons--
CM secreted by Caco-2
cells contained apoB100 and apoB48, and the apoB100:apoB48 ratio was
similar in smaller and larger lipoproteins, indicating that both these
apolipoproteins could be efficiently utilized for CM assembly. This is
in accordance with data obtained from transgenic mice that showed that
expression of apoB100 in intestinal cells results in efficient
transport of dietary fat (11, 12). Thus, it appears that CM assembly is
not a unique property of apoB48 but is a characteristic property of enterocytes.
CM secreted by Caco-2 cells also contained several exchangeable
apolipoproteins. The apolipoprotein composition of CM (Fig. 2) secreted
by Caco-2 cells was similar to that of lymph CM except for the
additional presence of apoB100 and apoE. Lymph CM do not contain these
two apolipoproteins because enterocytes do not synthesize them. CM
appear to contain more exchangeable apolipoproteins than VLDL (Fig. 2).
This probably reflects the larger surface area in CM available for
their association. Thus, synthesis of individual apolipoproteins at the
site of CM assembly and the surface area available on these particles
may determine the association of exchangeable apolipoproteins with
CM.
The small CM represent an interesting population of lipoproteins. Based
on several parameters (TG:PL ratio, Pluronic L81 sensitivity), they
resemble VLDL particles and can be called large VLDL. However, based on
apolipoprotein composition and TG mass they resemble CM. It has been
well documented that lipoproteins isolated by ultracentrifugation
represent a heterogeneous population of particles of varying sizes (25,
40, 45). Thus, the different lipoprotein fractions separated as
distinct populations based on flotation properties in these studies
most likely represent a continuum of particles of different sizes.
Insights into Chylomicron Assembly--
The radiolabeling
experiments involving glycerol provided some insights into the
synthesis, intracellular storage, and secretion of lipids by Caco-2
cells (Fig. 4). When cells were provided with radiolabeled glycerol and
challenged with OA under conditions that stimulate CM secretion, the
Caco-2 cells first synthesized PL. PL synthesis rates quickly reached a
plateau with a modest increase in cellular PL levels. This is
consistent with the tight cellular regulation of PL synthesis (for
reviews, see Refs. 54 and 55). Subsequently, synthesis of TG was
induced leading to a 4-fold increase in the intracellular TG pool. This
is entirely predictable because TG is the preferred form of stored
intracellular lipids. In contrast to the type and amounts of lipids
synthesized, Caco-2 cells preferentially used nascent TG and preformed
PL for CM assembly. However, it is important to note that a substantial amount of preformed TG is also used for CM assembly because the preformed:nascent TG ratio is remarkably constant over time (Fig. 4).
Thus, it appears that nascent PL and TG do not quickly equilibrate with
other cellular pools. Instead, newly synthesized lipids are sequestered
into new pools that are used for different purposes. In the current
study, no attempts were made to obtain information concerning the fate
of nascent PL. In the long term, this may replace the preformed PL pool
used for CM assembly and secretion. In the case of TG, the newly
synthesized pool appears to be used first for secretion and
subsequently for storage.
It has been documented from very early feeding studies that the fatty
acid composition of TG, not PL, in CM reflects dietary fatty acids (25,
39, 41, 56). Furthermore, it has been demonstrated that the
contribution of endogenous fatty acids to PL was much greater than it
was to TG of secreted CM, and that the overall fatty acid composition
of PL was relatively constant and independent of dietary composition
(39, 56). These differences have generally been attributed to
differences in activities and substrate specificities of enzymes
involved in TG and PL syntheses. Our observations that preformed PL and
nascent TG are preferentially used for CM assembly provide a different
explanation for these observations. In the postprandial state, newly
absorbed fatty acids are used for TG synthesis and this TG is
preferentially targeted for secretion as part of CM. In contrast,
preformed cellular PL pools which might have derived their fatty acids
from a previous meal, from biliary lipids, or cell debris are
preferentially used for CM assembly and thus do not contain dietary
fatty acids.
In the intestinal cells, assembly of VLDL and CM has been postulated to
occur by two independent pathways because CM secretion is specifically
inhibited by Pluronic L81 (for reviews, see Refs. 1, 15, and 57). In
the present study, we observed that preformed PL are preferentially
incorporated into VLDL and CM indicating that the initial step in the
assembly of these particles may be similar. Thus, the first step in the
assembly of both these particles may involve a detachment of preformed
PL from the ER membrane in association with nascent apoB resulting in
the release of a "primordial particle" into the lumen of the
endoplasmic reticulum. Since, nascent PL are not preferentially
incorporated in lipoproteins, it can be speculated that nascent PL are
not targeted to the site of primordial lipoprotein assembly in the
endoplasmic reticulum membrane and that ongoing synthesis of PL may not
contribute to this step. In contrast to PL, secreted VLDL contains
equal amounts of nascent and preformed TG whereas small and large CM
contain increased amounts of nascent TG. Thus, in the intestinal cells, assembly of larger lipoproteins of different size may occur by a second
process of "core expansion." In this process, the size of the
nascent lipoproteins may be critically dependent on the synthesis,
presumably at smooth endoplasmic reticulum, and delivery of nascent TG
to primordial particles. Pluronic L81, at low concentrations, may be a
specific inhibitor for the delivery of large boluses of TG, presumably
in the form of droplets, and may not affect the delivery of smaller
droplets to primordial particles. At higher concentrations ( 8
µg/ml) it might inhibit delivery of smaller droplets to the
primordial particles. Thus, the size of the secreted particle may
depend on the synthesis and delivery of nascent TG to primordial
particles and the extent of core expansion.
Knowledge concerning the assembly of intestinal lipoproteins has lagged
behind our understanding of the assembly of hepatic lipoprotein
assembly. This is mainly due to a lack of an appropriate cell culture
model (reviewed in Ref. 3). Here, we have provided a cell culture model
that produces CM. We recognize the limitations of any cell culture
model as a surrogate for animal intestinal lipoprotein assembly and
secretion. Nonetheless, the cell culture model described in this paper
may be useful in furthering our understanding of the molecular
mechanisms of intestinal lipoprotein assembly, to identify factors that
modulate CM assembly and secretion, and to study the effect of various
drugs and dietary components on the assembly and secretion of these
particles. It has already helped us in delineating the origins of TG
and PL pools utilized for lipoprotein assembly (Fig. 4). Moreover, it
may be useful to study in vitro absorption and transport of
various lipophilic drugs under postprandial conditions.
 |
ACKNOWLEDGEMENTS |
Technical assistance of Neeru Nayak and
Eugene Jiwanmall, and critical reading of the manuscript by Drs. Julian
Marsh and Michael Phillips are gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants DK-46900 and HL-22633 and the American Heart Association (National Center).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: AtheroGenics Inc., 8995 West Side Pkwy.,
Alpharetta, GA 30004.
§
Established investigator of the American Heart Association. To whom
correspondence should be addressed: Dept. of Biochemistry, MCP
Hahnemann University, 2900 Queen Lane, Philadelphia, PA 19129. Tel:
215-991-8497; Fax: 215-843-8849; E-mail: Hussaim@wpo.auhs.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
CM, chylomicrons;
apo, apolipoprotein;
FBS, fetal bovine serum;
BSA, bovine serum
albumin;
OA, oleic acid;
TC, taurocholate;
VLDL, very low density
lipoproteins.
 |
REFERENCES |
| 1.
|
Levy, E.,
Mehran, M.,
and Seidman, E.
(1995)
FASEB J.
9,
626-635[Abstract]
|
| 2.
|
Field, F. J.,
and Mathur, S. N.
(1995)
Prog. Lipid Res.
34,
185-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hussain, M. M.,
Kancha, R. K.,
Zhou, Z.,
Luchoomun, J.,
Zu, H.,
and Bakillah, A.
(1996)
Biochim. Biophys. Acta
1300,
151-170[Medline]
[Order article via Infotrieve]
|
| 4.
|
Dashti, N.
(1991)
Prog. Lipid Res.
30,
219-230[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hughes, T. E.,
Sasak, W. V.,
Ordovas, J. M.,
Forte, T. M.,
Lamon-Fava, S.,
and Schaefer, E. J.
(1987)
J. Biol. Chem.
262,
3762-3767[Abstract/Free Full Text]
|
| 6.
|
Moberly, J. B.,
Cole, T. G.,
and Schonfeld, G.
(1990)
Biochim. Biophys. Acta
1042,
70-80[Medline]
[Order article via Infotrieve]
|
| 7.
|
Hughes, T. E.,
Ordovas, J. M.,
and Schaefer, E. J.
(1988)
J. Biol. Chem.
263,
3425-3431[Abstract/Free Full Text]
|
| 8.
|
Traber, M. G.,
Kayden, H. J.,
and Rindler, M. J.
(1987)
J. Lipid Res.
28,
1350-1363[Abstract]
|
| 9.
|
Murthy, S.,
Albright, E.,
Mathur, S. N.,
Davidson, N. O.,
and Field, F. J.
(1992)
Arterioscler. Thromb.
12,
691-700[Abstract/Free Full Text]
|
| 10.
|
Luchoomun, J.,
Zhou, Z.,
Bakillah, A.,
Jamil, H.,
and Hussain, M. M.
(1997)
Arterioscler. Thromb. Vasc. Biol.
17,
2955-2963[Abstract/Free Full Text]
|
| 11.
|
Farese, R. V., Jr.,
Veniant, M. M.,
Cham, C. M.,
Flynn, L. M.,
Pierotti, V.,
Loring, J. F.,
Traber, M.,
Ruland, S.,
Stokowski, R. S.,
Huszar, D.,
and Young, S. G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6393-6398[Abstract/Free Full Text]
|
| 12.
|
Kim, E.,
and Young, S. G.
(1998)
J. Lipid Res.
39,
703-723[Abstract/Free Full Text]
|
| 13.
|
Ockner, R. K.,
Hughes, F. B.,
and Isselbacher, K. J.
(1969)
J. Clin. Invest.
48,
2079-2088
|
| 14.
|
Ockner, R. K.,
Hughes, F. B.,
and Isselbacher, K. J.
(1969)
J. Clin. Invest.
48,
2367-2373
|
| 15.
|
Tso, P.,
Drake, D. S.,
Black, D. D.,
and Sabesin, S. M.
(1984)
Am. J. Physiol.
247,
G599-G610[Abstract/Free Full Text]
|
| 16.
|
Tso, P.,
Balint, J. A.,
and Rodgers, J. B.
(1980)
Am. J. Physiol.
239,
G348-G353[Abstract/Free Full Text]
|
| 17.
|
Tso, P.,
Buch, K. L.,
Balint, J. A.,
and Rodgers, J. B.
(1982)
Am. J. Physiol.
242,
G408-G415[Abstract/Free Full Text]
|
| 18.
|
Hussain, M. M.,
Zhao, Y.,
Kancha, R. K.,
Blackhart, B. D.,
and Yao, Z.
(1995)
Arterioscler. Thromb. Vasc. Biol.
15,
485-494[Abstract/Free Full Text]
|
| 19.
|
Bakillah, A.,
Zhou, Z.,
Luchoomun, J.,
and Hussain, M. M.
(1997)
Lipids
32,
1113-1118[Medline]
[Order article via Infotrieve]
|
| 20.
|
Trotter, P. J.,
and Storch, J.
(1991)
J. Lipid Res.
32,
293-304[Abstract]
|
| 21.
|
Ranheim, T.,
Gedde-Dahl, A.,
Rustan, A. C.,
and Drevon, C. A.
(1992)
J. Lipid Res.
33,
1281-1293[Abstract]
|
| 22.
|
Hussain, M. M.,
Mahley, R. W.,
Boyles, J. K.,
Fainaru, M.,
Brecht, W. J.,
and Lindquist, P. A.
(1989)
J. Biol. Chem.
264,
9571-9582[Abstract/Free Full Text]
|
| 23.
|
Hussain, M. M.,
Mahley, R. W.,
Boyles, J. K.,
Lindquist, P. A.,
Brecht, W. J.,
and Innerarity, T. L.
(1989)
J. Biol. Chem.
264,
17931-17938[Abstract/Free Full Text]
|
| 24.
|
Karpe, F.,
Hamsten, A.,
Uffelman, K.,
and Steiner, G.
(1996)
Methods Enzymol.
263,
95-104[Medline]
[Order article via Infotrieve]
|
| 25.
|
Dole, V. P.,
and Hamlin, J. T., III
(1962)
Physiol. Rev.
42,
674-701[Free Full Text]
|
| 26.
|
Milne, R. W.,
Theolis, R., Jr.,
Verdery, R. B.,
and Marcel, Y. L.
(1983)
Arteriosclerosis
3,
23-30[Abstract/Free Full Text]
|
| 27.
|
Pease, R. J.,
Milne, R. W.,
Jessup, W. K.,
Law, A.,
Provost, P.,
Fruchart, J. C.,
Dean, R. T.,
Marcel, Y. L.,
and Scott, J.
(1990)
J. Biol. Chem.
265,
553-568[Abstract/Free Full Text]
|
| 28.
|
Mindham, M. A.,
and Mayes, P. A.
(1992)
J. Lipid Res.
33,
1084-1088[Abstract]
|
| 29.
|
Dashti, N.,
Smith, E. A.,
and Alaupovic, P.
(1990)
J. Lipid Res.
31,
113-123[Abstract]
|
| 30.
|
Field, F. J.,
Albright, E.,
and Mathur, S. N.
(1988)
J. Lipid Res.
29,
1427-1437[Abstract]
|
| 31.
|
Van Greevenbroek, M. M. J.,
Robertus-Teunissen, M. G.,
Erkelens, D. W.,
and De Bruin, T. W. A.
(1998)
J. Lipid Res.
39,
173-185[Abstract/Free Full Text]
|
| 32.
|
Ranheim, T.,
Gedde-Dahl, A.,
Rustan, A. C.,
and Drevon, C. A.
(1994)
Biochim. Biophys. Acta
1212,
295-304[Medline]
[Order article via Infotrieve]
|
| 33.
|
Field, F. J.,
Born, E.,
Chen, H. S.,
Murthy, S.,
and Mathur, S. N.
(1994)
J. Lipid Res.
35,
749-762[Abstract]
|
| 34.
|
Van Greevenbroek, M. M. J.,
vanMeer, G.,
Erkelens, D. W.,
and De Bruin, T. W. A.
(1996)
Atherosclerosis
121,
139-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Tso, P.,
Lindstrom, M. B.,
and Borgstrom, B.
(1987)
Biochim. Biophys. Acta
922,
304-313[Medline]
[Order article via Infotrieve]
|
| 36.
|
Herscovitz, H.,
Kritis, A.,
Talianidis, I.,
Zanni, E.,
Zannis, V.,
and Small, D. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
659-663[Abstract/Free Full Text]
|
| 37.
|
Wiggins, D.,
and Gibbons, G. F.
(1996)
Biochem. J.
320,
673-679
|
| 38.
|
Gibbons, G. F.,
Khurana, R.,
Odwell, A.,
and Seelaender, M. C.
(1994)
J. Lipid Res.
35,
1801-1808[Abstract]
|
| 39.
|
Whyte, M.,
Karmen, A.,
and Goodman, D. S.
(1963)
J. Lipid Res.
4,
322-329[Abstract]
|
| 40.
|
Fraser, R.
(1970)
J. Lipid Res.
11,
60-65[Abstract]
|
| 41.
|
Redgrave, T. G.,
and Dunne, K. B.
(1975)
Atherosclerosis
22,
389-400[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Fraser, R.,
Cliff, W. J.,
and Courtice, F. C.
(1968)
Q. J. Exp. Physiol.
53,
390-398
|
| 43.
|
Renner, F.,
Samuelson, A.,
Rogers, M.,
and Glickman, R. M.
(1986)
J. Lipid Res.
27,
72-81[Abstract]
|
| 44.
|
Glickman, R. M.,
Kirsch, K.,
and Isselbacher, K. J.
(1972)
J. Clin. Invest.
51,
356-363
|
| 45.
|
Anderson, L. J.,
Boyles, J. K.,
and Hussain, M. M.
(1989)
J. Lipid Res.
30,
1819-1824[Abstract]
|
| 46.
|
Gantz, D.,
Bennett Clark, S.,
Derksen, A.,
and Small, D. M.
(1990)
J. Lipid Res.
31,
163-171[Abstract]
|
| 47.
|
Tso, P.,
Balint, J. A.,
Bishop, M. B.,
and Rodgers, J. B.
(1981)
Am. J. Physiol.
241,
G487-G497[Abstract/Free Full Text]
|
| 48.
|
Tso, P.,
and Gollamudi, S. R.
(1984)
Am. J. Physiol.
247,
G32-G36[Abstract/Free Full Text]
|
| 49.
|
Levin, M. S.,
Talkad, V. D.,
Gordon, J. I.,
and Stenson, W. F.
(1992)
J. Lipid Res.
33,
9-19[Abstract]
|
| 50.
|
Gedde-Dahl, A.,
Ranheim, T.,
Drevon, C. A.,
Skrede, S.,
Berge, R. K.,
and Rustan, A. C.
(1995)
J. Lipid Res.
36,
535-543[Abstract]
|
| 51.
|
Ranheim, T.,
Gedde-Dahl, A.,
Rustan, A. C.,
and Drevon, C. A.
(1994)
Biochem. J.
303,
155-161
|
| 52.
|
Hamilton, J. A.
(1998)
J. Lipid Res.
39,
467-481[Abstract/Free Full Text]
|
| 53.
|
Abumrad, N.,
Harmon, C.,
and Ibrahimi, A.
(1998)
J. Lipid Res.
39,
2309-2318[Abstract/Free Full Text]
|
| 54.
|
Pelech, S. L.,
and Vance, D. E.
(1984)
Biochim. Biophys. Acta
779,
217-251[Medline]
[Order article via Infotrieve]
|
| 55.
|
Vance, D. E.
(1990)
Biochem. Cell Biol.
68,
1151-1165[Medline]
[Order article via Infotrieve]
|
| 56.
|
Kayden, H. J.,
Karmen, A.,
and Dumont, A.
(1963)
J. Clin. Invest.
42,
1373-1381
|
| 57.
|
Tso, P.,
and Balint, J. A.
(1986)
Am. J. Physiol.
250,
G715-G726
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Iqbal and M. M. Hussain
Intestinal lipid absorption
Am J Physiol Endocrinol Metab,
June 1, 2009;
296(6):
E1183 - E1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Masuda, K.-i. Hirano, H. Oku, J. C. Sandoval, R. Kawase, M. Yuasa-Kawase, Y. Yamashita, M. Takada, K. Tsubakio-Yamamoto, Y. Tochino, et al.
Chylomicron remnants are increased in the postprandial state in CD36 deficiency
J. Lipid Res.,
May 1, 2009;
50(5):
999 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ghoshal, J. Witta, J. Zhong, W. de Villiers, and E. Eckhardt
Chylomicrons promote intestinal absorption of lipopolysaccharides
J. Lipid Res.,
January 1, 2009;
50(1):
90 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Reboul, D. Trompier, M. Moussa, A. Klein, J.-F. Landrier, G. Chimini, and P. Borel
ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of {alpha}- and {gamma}-tocopherol but not in that of retinyl palmitate in mice
Am. J. Clinical Nutrition,
January 1, 2009;
89(1):
177 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cheng, J. Iqbal, J. Devenny, C.-H. Chu, L. Chen, J. Dong, R. Seethala, W. J. Keim, A. V. Azzara, R. M. Lawrence, et al.
Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1): FUNCTIONAL IMPORTANCE OF DGAT1 IN THE INTESTINAL FAT ABSORPTION
J. Biol. Chem.,
October 31, 2008;
283(44):
29802 - 29811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Iqbal, L. L. Rudel, and M. M. Hussain
Microsomal Triglyceride Transfer Protein Enhances Cellular Cholesteryl Esterification by Relieving Product Inhibition
J. Biol. Chem.,
July 18, 2008;
283(29):
19967 - 19980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Failla, C. Chitchumroonchokchai, and B. K. Ishida
In Vitro Micellarization and Intestinal Cell Uptake of cis Isomers of Lycopene Exceed Those of All-trans Lycopene
J. Nutr.,
March 1, 2008;
138(3):
482 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. During and E. H. Harrison
Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells
J. Lipid Res.,
October 1, 2007;
48(10):
2283 - 2294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Anwar, J. Iqbal, and M. M. Hussain
Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption
J. Lipid Res.,
September 1, 2007;
48(9):
2028 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Liu, J. Iqbal, C. Yeang, D. Q.-H. Wang, M. M. Hussain, and X.-C. Jiang
Phospholipid Transfer Protein-Deficient Mice Absorb Less Cholesterol
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2007;
27(9):
2014 - 2021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Pan, F. N. Hussain, J. Iqbal, M. H. Feuerman, and M. M. Hussain
Inhibiting Proteasomal Degradation of Microsomal Triglyceride Transfer Protein Prevents CCl4-induced Steatosis
J. Biol. Chem.,
June 8, 2007;
282(23):
17078 - 17089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Qin, W. Qiu, R. K. Avramoglu, and K. Adeli
Tumor Necrosis Factor-{alpha} Induces Intestinal Insulin Resistance and Stimulates the Overproduction of Intestinal Apolipoprotein B48-Containing Lipoproteins
Diabetes,
February 1, 2007;
56(2):
450 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fatma, R. Yakubov, K. Anwar, and M. M. Hussain
Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion
J. Lipid Res.,
November 1, 2006;
47(11):
2422 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Anwar, H. J. Kayden, and M. M. Hussain
Transport of vitamin E by differentiated Caco-2 cells
J. Lipid Res.,
June 1, 2006;
47(6):
1261 - 1273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chitchumroonchokchai and M. L. Failla
Hydrolysis of Zeaxanthin Esters by Carboxyl Ester Lipase during Digestion Facilitates Micellarization and Uptake of the Xanthophyll by Caco-2 Human Intestinal Cells
J. Nutr.,
March 1, 2006;
136(3):
588 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. During, H. D. Dawson, and E. H. Harrison
Carotenoid Transport Is Decreased and Expression of the Lipid Transporters SR-BI, NPC1L1, and ABCA1 Is Downregulated in Caco-2 Cells Treated with Ezetimibe
J. Nutr.,
October 1, 2005;
135(10):
2305 - 2312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Iqbal and M. M. Hussain
Evidence for multiple complementary pathways for efficient cholesterol absorption in mice
J. Lipid Res.,
July 1, 2005;
46(7):
1491 - 1501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Reboul, P. Borel, C. Mikail, L. Abou, M. Charbonnier, C. Caris-Veyrat, P. Goupy, H. Portugal, D. Lairon, and M.-J. Amiot
Enrichment of Tomato Paste with 6% Tomato Peel Increases Lycopene and {beta}-Carotene Bioavailability in Men
J. Nutr.,
April 1, 2005;
135(4):
790 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Deforges, A. Evlashev, M. Perret, M. Sodoyer, S. Pouzol, J.-Y. Scoazec, B. Bonnaud, O. Diaz, G. Paranhos-Baccala, V. Lotteau, et al.
Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo
J. Gen. Virol.,
September 1, 2004;
85(9):
2515 - 2523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chitchumroonchokchai, S. J. Schwartz, and M. L. Failla
Assessment of Lutein Bioavailability from Meals and a Supplement Using Simulated Digestion and Caco-2 Human Intestinal Cells
J. Nutr.,
September 1, 2004;
134(9):
2280 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Casaschi, G. K. Maiyoh, B. K. Rubio, R. W. Li, K. Adeli, and A. G. Theriault
The Chalcone Xanthohumol Inhibits Triglyceride and Apolipoprotein B Secretion in HepG2 Cells
J. Nutr.,
June 1, 2004;
134(6):
1340 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Iqbal, K. Anwar, and M. M. Hussain
Multiple, Independently Regulated Pathways of Cholesterol Transport across the Intestinal Epithelial Cells
J. Biol. Chem.,
August 22, 2003;
278(34):
31610 - 31620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Sellers, L. Hou, H. Athar, M. M. Hussain, and G. S. Shelness
A Drosophila Microsomal Triglyceride Transfer Protein Homolog Promotes the Assembly and Secretion of Human Apolipoprotein B: IMPLICATIONS FOR HUMAN AND INSECT LIPID TRANSPORT AND METABOLISM
J. Biol. Chem.,
May 23, 2003;
278(22):
20367 - 20373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kummrow, M. M. Hussain, M. Pan, J. B. Marsh, and E. A. Fisher
Myristic acid increases dense lipoprotein secretion by inhibiting apoB degradation and triglyceride recruitment
J. Lipid Res.,
December 1, 2002;
43(12):
2155 - 2163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Singh, O. A. Batuman, H. O. Akman, M. H. Kedees, V. Vakil, and M. M. Hussain
Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor beta
J. Biol. Chem.,
October 11, 2002;
277(42):
39515 - 39524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. During, M. M. Hussain, D. W. Morel, and E. H. Harrison
Carotenoid uptake and secretion by CaCo-2 cells: {beta}-carotene isomer selectivity and carotenoid interactions
J. Lipid Res.,
July 1, 2002;
43(7):
1086 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Dixon, J. Biddle, C.-m. Lo, J. D. Stoops, H. Li, N. Sakata, and T. E. Phillips
Apolipoprotein B Is Synthesized in Selected Human Non-hepatic Cell Lines But Not Processed into Mature Lipoprotein
J. Histochem. Cytochem.,
May 1, 2002;
50(5):
629 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Kirby, S. Zheng, P. Tso, P. N. Howles, and D. Y. Hui
Bile Salt-stimulated Carboxyl Ester Lipase Influences Lipoprotein Assembly and Secretion in Intestine. A PROCESS MEDIATED VIA CERAMIDE HYDROLYSIS
J. Biol. Chem.,
February 1, 2002;
277(6):
4104 - 4109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Cartwright and J. A. Higgins
Direct Evidence for a Two-step Assembly of ApoB48-containing Lipoproteins in the Lumen of the Smooth Endoplasmic Reticulum of Rabbit Enterocytes
J. Biol. Chem.,
December 14, 2001;
276(51):
48048 - 48057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Ho and J. Storch
Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells
Am J Physiol Cell Physiol,
October 1, 2001;
281(4):
C1106 - C1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Harrison and M. M. Hussain
Mechanisms Involved in the Intestinal Digestion and Absorption of Dietary Vitamin A
J. Nutr.,
May 1, 2001;
131(5):
1405 - 1408.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Nayak, E. H. Harrison, and M. M. Hussain
Retinyl ester secretion by intestinal cells: a specific and regulated process dependent on assembly and secretion of chylomicrons
J. Lipid Res.,
February 1, 2001;
42(2):
272 - 280.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. J. Cartwright, D. Plonné, and J. A. Higgins
Intracellular events in the assembly of chylomicrons in rabbit enterocytes
J. Lipid Res.,
November 1, 2000;
41(11):
1728 - 1739.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Bakillah and M. M. Hussain
Binding of Microsomal Triglyceride Transfer Protein to Lipids Results in Increased Affinity for Apolipoprotein B. EVIDENCE FOR STABLE MICROSOMAL MTP-LIPID COMPLEXES
J. Biol. Chem.,
August 10, 2001;
276(33):
31466 - 31473.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|